Dear colleagues,
Here at last is the QC-survey for geuvadis. I kindly ask each partner to
answer it and send back to me by *11 August* at the latest.
As the survey covers both laboratory details and bioinformatics I
suggest that each principal investigator at each site delegates the task
to the appropriate person(s).
For question 11 and 22: You don't have to describe every data analysis
pipeline you have, that would be to much to ask. Please choose one or
two you use the most and/or one that you have particular expertise in.
Please don't hesitate to ask me if there is something that is unclear.
Thank you and best summer greetings to all of you.
Mathias
--
_____________________________________________
Mathias Brännvall, PhD
Project coordinator
Dept. of Medical Sciences, sect. Molecular Medicine,
Uppsala University
Akademiska sjukhuset, ing. 70, 3 tr
phone: +46-(0)18-6114934
mobile: +46-(0)70-1679446
e-mail: Mathias.Brannvall(a)medsci.uu.se
Dear all
I attach the current draft of the RNA-seq QC paper, which was submitted as supplementary material for the main paper.
We intend to submit the QC paper to Nat Biotechnology within the coming weeks.
Please send your comments and edits (with track changes) to the current draft ulitmately December 21st
Have a very good X-mas!
Best wishes
Peter
Dr. Peter A.C. 't Hoen
Center for Human and Clinical Genetics
Leiden University Medical Center
Postal zone S4-P
PO Box 9600
2300 RC Leiden
The Netherlands
phone: +31-71-5269421
fax: +31-71-5268285
e-mail: p.a.c.hoen(a)lumc.nl
